IL1RAPL1 controls inhibitory networks during cerebellar development in mice.

Fiche publication


Date publication

octobre 2009

Journal

The European journal of neuroscience

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CHELLY Jamel, Dr VITALE Nicolas


Tous les auteurs :
Gambino F, Kneib M, Pavlowsky A, Skala H, Heitz S, Vitale N, Poulain B, Khelfaoui M, Chelly J, Billuart P, Humeau Y

Résumé

Abnormalities in the formation and function of cerebellar circuitry potentially contribute to cognitive deficits in humans. In the adult, the activity of the sole output neurons of the cerebellar cortex - the Purkinje cells (PCs) - is shaped by the balance of activity between local excitatory and inhibitory circuits. However, how this balance is established during development remains poorly understood. Here, we investigate the role of interleukin-1 receptor accessory protein-like 1 (IL1RAPL1), a protein linked to cognitive function which interacts with neuronal calcium sensor 1 (NCS-1) in the development of mouse cerebellum. Using Il1rapl1-deficient mice, we found that absence of IL1RAPL1 causes a transient disinhibition of deep cerebellar nuclei neurons between postnatal days 10 and 14 (P10/P14). Upstream, in the cerebellar cortex, we found developmental perturbations in the activity level of molecular layer interneurons (MLIs), resulting in the premature appearance of giant GABAA-mediated inhibitory post-synaptic currents capable of silencing PCs. Examination of feed-forward recruitment of MLIs by parallel fibres shows that during this P10/P14 time window, MLIs were more responsive to incoming excitatory drive. Thus, we conclude that IL1RAPL1 exerts a key function during cerebellar development in establishing local excitation/inhibition balance.

Mots clés

Anesthetics, Local, pharmacology, Animals, Animals, Newborn, Biophysics, Calbindins, Cerebellum, cytology, Electric Stimulation, methods, Excitatory Amino Acid Antagonists, pharmacology, Gene Expression Regulation, Developmental, genetics, In Vitro Techniques, Inhibitory Postsynaptic Potentials, drug effects, Interleukin-1 Receptor-Like 1 Protein, Mice, Mice, Knockout, Neural Inhibition, drug effects, Neuronal Calcium-Sensor Proteins, metabolism, Neurons, drug effects, Neuropeptides, metabolism, Parvalbumins, metabolism, Patch-Clamp Techniques, methods, Quinoxalines, pharmacology, Receptors, Interleukin, deficiency, S100 Calcium Binding Protein G, metabolism, Tetrodotoxin, pharmacology

Référence

Eur. J. Neurosci.. 2009 Oct;30(8):1476-86